Cefatrizine is an inhibitor of eukaryotic elongation factor-2 kinase, a unique calcium/calmodulin-dependent protein kinase, is well known to regulate apoptosis, autophagy and ERstress in many types of human cancers.
KM10103 exhibits β-cell-protective activities against ERstress, which plays an important role in the decline in pancreatic β cell function and mass observed in type 2 diabetes.